Brooks Life Sciences to Present, Host and Exhibit at Phacilitate Cell and Gene Therapy Conference

CHELMSFORD, Mass.--()--Brooks Life Sciences, global leader in automated solutions for temperature-controlled storage and management of compounds and biological samples, today announced the company’s participation in Phacilitate Cell and Gene Therapy 2018 conference.

David Lewandowski, Brooks Life Sciences’ Global Product Manager and ISBER President-Elect, will present at the Networking and Educational Symposium Dinner. This exclusive, by-invitation-only event will take place on Tuesday, January 23, 2018, at 7:15 PM. Comprised of thought-leaders in sample handling and cryopreservation, panelists will discuss best practices and the impact of proper storage and handling processes on cellular therapeutic viability. To express interest in attending this event, please contact Roger Morency.

Visitors at booth #206, will get the chance to interact with Brooks’ newly released BioStore™ III Cryo, Automated Cryogenic Storage System. With intuitive software and advanced security features, the automated LN2 system is the only cryogenic storage solution that combines sample protection, safety and accessibility of a manual high-efficiency LN2 vapor freezer with advanced automation features such as inventory management, cold-chain management and a superior ergonomic user experience.

Additionally, the company will participate in the Supply Chain Logistics Hub, discussing the unique challenges researchers face when cryopreserving advanced therapies. The Hub is held from January 23-25. To book a time slot with Brooks please click here.

“We participate in this event annually to help scientists and researchers manage, track and document samples, which is paramount in today’s highly regulated environment,” said Lewandowski. “There are many steps in cell therapy product development where cell viability can be jeopardized and the Brooks’ team at Phacilitate can help customers navigate cryopreservation, cold-chain and sample management challenges.”

The conference runs from January 22-25, 2018, at the Hyatt Regency in Miami, Florida.

For more information about Brooks please contact David Lewandowski at David.Lewandowski@brooks.com or visit us at booth #206. For more information on the Phacilitate Cell and Gene Therapy World click here.

About Brooks Life Sciences

Brooks Life Sciences, a division of Brooks Automation, is the leading worldwide provider of innovative and comprehensive sample lifecycle management solutions for the bioscience industry. These solutions include our automated storage systems, sample consumables and instruments, cell cryopreservation storage products, onsite and offsite temperature-controlled storage models, global sample preparation and analytical lab services, and innovative informatics systems and technology services. Our team of sample management experts delivers high quality, flexible sample management products, services and technology solutions that support hundreds of bioscience customers around the world, including the top 20 biopharmaceutical companies. Our industry-leading sample management solutions enable our customers to unlock sample intelligence and advance scientific research in order to deliver healthier and brighter tomorrows to individuals around the world.

Contacts

Brooks Life Sciences
Tara Dripps, +1 (317) 452-8531
Tara.Dripps@brooks.com

Release Summary

Brooks Life Sciences to Present, Host and Exhibit at Phacilitate Cell and Gene Therapy Conference

Contacts

Brooks Life Sciences
Tara Dripps, +1 (317) 452-8531
Tara.Dripps@brooks.com